3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Glioblastoma
7
Urinary Bladder Neoplasms
5
Glioma
5
Prostatic Neoplasms
4
Lung Neoplasms
4
Esophageal Neoplasms
4
Burkitt Lymphoma
4
Breast Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
3
Oropharyngeal Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Carcinoma
3
Astrocytoma
3
Uterine Cervical Neoplasms
2
Sarcoma, Ewing
2
Sarcoma
2
Pancreatic Neoplasms
2
Neoplasm Metastasis
2
Mouth Neoplasms
2
Mesothelioma, Malignant
2
Melanoma
2
Laryngeal Neoplasms
2
Gliosarcoma
2
Ganglioneuroblastoma
2
Brain Neoplasms
2
Adenocarcinoma of Lung
2
Wilms Tumor
1
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Triple Negative Breast Neoplasms
1
Interventions
lutetium Lu 177 dotatate
5
Specimen Handling
3
Magnetic Resonance Spectroscopy
3
pembrolizumab
2
olaparib
2
fludarabine
2
cabozantinib
2
X-Rays
2
Phantoms, Imaging
2
Cyclophosphamide
2
tivozanib
1
repotrectinib
1
pazopanib
1
fludarabine phosphate
1
entrectinib
1
belinostat
1
atezolizumab
1
aldesleukin
1
Yttrium-90
1
Tomography, X-Ray Computed
1
Tomography, Emission-Computed, Single-Photon
1
Temozolomide
1
Single Photon Emission Computed Tomography Computed Tomography
1
Salts
1
Positron Emission Tomography Computed Tomography
1
PT-100 dipeptide
1
Octreotide
1
Nivolumab
1
Introns
1
Interferon alpha-2
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neuroendocrine Tumors
×
Radiation
×
30 days
×
Clear all
No trials found.